查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108316

2035年前牙周炎軟膏市場分析和預測 ：按類型、產品、技術、成分、應用、劑型、最終用戶、功能和模式分類。

Periodontitis Ointments Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Form, End User, Functionality, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球牙周炎軟膏市場預計將從2025年的8億美元成長到2035年的14億美元，複合年成長率（CAGR）為5.8%。牙周炎軟膏市場結構較為集中，其中抗菌軟膏約佔45%的市場佔有率，其次是抗發炎軟膏（35%）和再生軟膏（20%）。主要應用包括治療慢性牙周炎和牙齦炎以及術後護理。市場規模主要以銷售量衡量，反映了牙科診所和醫院的需求。市場集中度受成熟製藥公司和新興生技公司的影響。

依應用領域分類，牙周炎軟膏市場可分為牙齦炎治療、牙周炎治療、術後護理、牙菌斑清除和其他用途。其中，預計到2025年，牙周炎治療領域將佔最大的市場佔有率。這一主導地位歸因於牙周疾病盛行率的上升、口腔衛生意識的增強以及對有效治療晚期牙齦感染疾病的需求不斷成長。牙周炎軟膏廣泛用於抑制細菌生長、減輕發炎和促進牙齦組織癒合，使其成為牙周護理的重要組成部分。牙科治療數量的增加、目標局部治療的廣泛應用以及藥膏製劑技術的進步，進一步鞏固了該領域在市場中的主導地位。

市場區隔
類型 抗生素軟膏、消炎軟膏、消毒軟膏、草藥軟膏等。
產品 複方軟膏、非處方藥膏、天然來源軟膏、藥用凝膠等。
科技 緩釋技術、奈米技術、生物黏附技術等。
成分 活性成分、添加物、防腐劑及其他
目的 治療牙齦炎、治療牙周炎、術後護理、清除牙菌斑及其他服務。
劑型 凝膠、乳霜、膏狀物、液體或其他
最終用戶 牙科診所、醫院、居家照護機構、藥局及其他
功能 緩解疼痛、抗菌、消炎、促進組織再生等。
模式 外用、漱口水等

從技術角度來看，牙周炎軟膏市場可細分為緩釋技術、奈米技術、生物黏附技術和其他技術。其中，生物黏附技術預計將在預測期內實現最快成長。其快速成長主要得益於生物黏附技術能夠增強藥物在受損牙周組織中的滯留，進而提高治療效果。與傳統局部黏附技術在牙周炎軟膏製劑中的應用。

區域概覽

到2025年，北美將佔牙周炎軟膏市場最大的佔有率。這主要得益於專業牙科服務的普及、人們對治療的高度重視以及局部牙周藥物療法的日益普及。該地區擁有先進的口腔健康基礎設施、強大的牙科產品製造商網路以及對微創治療方案不斷成長的需求。人口老化導致牙周疾病盛行率上升，加上定期牙科檢查計畫和優惠的保險報銷政策，持續推動產品的普及。牙周治療領域的持續創新進一步鞏固了北美在全球市場的主導地位。

預計亞太地區將在預測期內保持最快成長，這主要得益於口腔健康意識的提高、牙科服務可近性的改善以及醫療基礎設施投資的增加。由於生活方式的改變和人口老化，中國、印度、日本和韓國等國家的牙周病盛行率正在上升。牙科專業人員數量的增加、牙科治療成本效益的提高以及政府推廣口腔健康預防的舉措，都在加速該地區的需求成長。局部用藥技術的持續進步和藥品生產能力的不斷擴大，預計將為市場的長期成長提供支撐。

主要趨勢和促進因素

對牙周病藥物局部給藥的需求日益成長

局部治療方法的日益普及推動了牙周炎軟膏市場的發展。牙醫師擴大使用局部牙周炎軟膏，將抗菌和抗發炎藥物直接輸送到受感染的牙齦組織，在提高治療效果的同時減少全身性藥物暴露。人們對牙周疾病早期治療的認知不斷提高、老年人口的成長以及糖尿病相關口腔併發症盛行率的上升，都促進了治療需求的成長。此外，牙科保健服務的可近性提高以及對預防性牙科的日益重視，也推動了已開發和新興醫療市場對局部牙周治療的採用。

緩釋局部製劑的進展

牙周炎軟膏市場的關鍵趨勢之一是開發緩釋型局部用藥製劑，以提供更持久的治療效果。製造商正在將可生物分解的聚合物、黏膜黏附材料和先進的藥物遞送技術應用於產品中，以增強軟膏在牙周袋內的滯留時間。這些創新提高了藥物吸收率，減少了重複用藥的需要，並改善了治療效果。抗菌劑組合、再生劑和奈米技術遞送系統的研究也在拓展治療的可能性。這些技術進步提高了患者的依從性，並推動了更有效的局部牙周治療方案的研發。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 抗生素軟膏
    • 消炎軟膏
    • 消毒軟膏
    • 草本軟膏
    • 其他
  • 市場規模及預測：依產品分類
    • 複方軟膏
    • 非處方藥膏
    • 天然來源的軟膏
    • 藥用凝膠
    • 其他
  • 市場規模及預測：依應用領域分類
    • 牙齦炎的治療
    • 牙周病的治療
    • 術後護理
    • 牙菌斑清除
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 牙醫診所
    • 醫院
    • 居家照護
    • 藥局
    • 其他
  • 市場規模及預測：以劑型分類
    • 凝膠
    • 奶油
    • 貼上
    • 液體
    • 其他
  • 市場規模及預測：依技術分類
    • 緩釋技術
    • 奈米科技
    • 生物黏附技術
    • 其他
  • 市場規模及預測：依組件分類
    • 活性成分
    • 輔料
    • 防腐劑
    • 其他
  • 市場規模及預測：依功能分類
    • 緩解疼痛
    • 抗菌
    • 消炎（藥）
    • 組織再生
    • 其他
  • 市場規模及預測：按模式
    • 外用
    • 漱口水
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • GlaxoSmithKline
  • Colgate-Palmolive
  • Procter & Gamble
  • Johnson & Johnson
  • Sunstar Group
  • 3M
  • Dentsply Sirona
  • Unilever
  • Henkel
  • Church & Dwight
  • Lion Corporation
  • GC Corporation
  • Ivoclar Vivadent
  • Straumann Group
  • Bausch Health
  • Septodont
  • Kao Corporation
  • Mundipharma
  • Pierre Fabre
  • Haleon

第9章 關於我們

簡介目錄
Product Code: GIS34667

The global Periodontitis Ointments Market is projected to grow from $0.8 billion in 2025 to $1.4 billion by 2035, at a compound annual growth rate (CAGR) of 5.8%. The Periodontitis Ointments Market is characterized by a moderately consolidated structure, with the top segments being antimicrobial ointments, holding approximately 45% market share, followed by anti-inflammatory ointments at 35%, and regenerative ointments at 20%. Key applications include treatment for chronic periodontitis, gingivitis, and post-surgical care. The market volume is primarily measured in units sold, reflecting the demand from dental clinics and hospitals. The market's concentration is influenced by the presence of established pharmaceutical companies and emerging biotech firms.

Based on Application, the Periodontitis Ointments Market is divided into Gingivitis Treatment, Periodontitis Treatment, Post-Surgical Care, Plaque Removal, and Others. Among these, the Periodontitis Treatment segment accounted for the largest market share in 2025. This dominance is attributed to the increasing prevalence of periodontal diseases, rising awareness regarding oral health, and growing demand for effective therapeutic solutions to manage advanced gum infections. Periodontitis ointments are widely used to reduce bacterial growth, control inflammation, and support gum tissue healing, making them an important component of periodontal care. The increasing number of dental procedures, higher adoption of targeted topical treatments, and advancements in medicated ointment formulations are further contributing to the segments leading position in the market.

Market Segmentation
TypeAntibiotic Ointments, Anti-inflammatory Ointments, Antiseptic Ointments, Herbal Ointments, Others
ProductPrescription Ointments, Over-the-Counter Ointments, Natural Ointments, Medicated Gels, Others
TechnologyControlled Release, Nanotechnology, Bioadhesive Technology, Others
ComponentActive Pharmaceutical Ingredients, Excipients, Preservatives, Others
ApplicationGingivitis Treatment, Periodontitis Treatment, Post-Surgical Care, Plaque Removal, Others
FormGel, Cream, Paste, Liquid, Others
End UserDental Clinics, Hospitals, Homecare Settings, Pharmacies, Others
FunctionalityPain Relief, Anti-bacterial, Anti-inflammatory, Tissue Regeneration, Others
ModeTopical Application, Oral Rinse, Others

Based on Technology, the Periodontitis Ointments Market is divided into Controlled Release, Nanotechnology, Bioadhesive Technology, and Others. Among these, the Bioadhesive Technology segment is projected to witness the fastest growth during the forecast period. The rapid growth of this segment is driven by its ability to enhance drug retention at the affected periodontal site and improve treatment effectiveness. Bioadhesive formulations allow prolonged contact between the active ingredients and gum tissues, resulting in better therapeutic outcomes compared with conventional topical applications. Increasing research and development activities focused on advanced drug delivery systems, along with the demand for minimally invasive and patient-friendly periodontal treatments, are expected to accelerate the adoption of bioadhesive technology in periodontitis ointment formulations.

Geographical Overview

North America accounted for the largest share of the Periodontitis Ointments Market in 2025 due to the widespread availability of specialized dental care services, high treatment awareness, and increasing adoption of localized periodontal drug therapies. The region benefits from advanced oral healthcare infrastructure, a strong presence of dental product manufacturers, and growing demand for minimally invasive treatment solutions. Increasing prevalence of gum diseases among aging populations, combined with routine dental screening programs and favorable reimbursement systems, continues to support product adoption. Continuous innovation in periodontal therapeutics further reinforces North America's leading position in the global market.

Asia-Pacific is projected to register the fastest growth throughout the forecast period owing to increasing oral healthcare awareness, improving access to dental services, and expanding investments in healthcare infrastructure. Countries such as China, India, Japan, and South Korea are witnessing rising incidences of periodontal diseases due to changing lifestyles and aging populations. Growing numbers of dental professionals, increasing affordability of dental treatments, and government initiatives promoting preventive oral healthcare are accelerating regional demand. Continuous improvements in localized drug delivery technologies and expanding pharmaceutical manufacturing capabilities are expected to support long-term market growth.

Key Trends and Drivers

Growing Demand for Localized Periodontal Drug Delivery:

The increasing preference for localized treatment approaches is driving the Periodontitis Ointments Market. Dentists are increasingly utilizing topical periodontal ointments to deliver antimicrobial and anti-inflammatory agents directly to infected gum tissues, improving therapeutic effectiveness while reducing systemic drug exposure. Rising awareness regarding early periodontal disease management, expanding geriatric populations, and increasing prevalence of diabetes-related oral complications are contributing to higher treatment demand. Additionally, improvements in dental care accessibility and greater emphasis on preventive oral health are encouraging the adoption of localized periodontal therapies across both developed and emerging healthcare markets.

Advancements in Controlled-Release Topical Formulations:

A major trend in the Periodontitis Ointments Market is the development of controlled-release topical formulations that provide prolonged therapeutic action. Manufacturers are incorporating biodegradable polymers, mucoadhesive materials, and advanced drug delivery technologies to enhance ointment retention within periodontal pockets. These innovations improve drug absorption, reduce the need for repeated applications, and enhance treatment outcomes. Research into antimicrobial combinations, regenerative agents, and nanotechnology-based delivery systems is also expanding therapeutic possibilities. These technological developments are improving patient compliance while supporting the evolution of more effective localized periodontal treatment solutions.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by End User
  • 2.5 Key Market Highlights by Form
  • 2.6 Key Market Highlights by Technology
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Antibiotic Ointments
    • 4.1.2 Anti-inflammatory Ointments
    • 4.1.3 Antiseptic Ointments
    • 4.1.4 Herbal Ointments
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Prescription Ointments
    • 4.2.2 Over-the-Counter Ointments
    • 4.2.3 Natural Ointments
    • 4.2.4 Medicated Gels
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Gingivitis Treatment
    • 4.3.2 Periodontitis Treatment
    • 4.3.3 Post-Surgical Care
    • 4.3.4 Plaque Removal
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by End User (2020-2035)
    • 4.4.1 Dental Clinics
    • 4.4.2 Hospitals
    • 4.4.3 Homecare Settings
    • 4.4.4 Pharmacies
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Form (2020-2035)
    • 4.5.1 Gel
    • 4.5.2 Cream
    • 4.5.3 Paste
    • 4.5.4 Liquid
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Technology (2020-2035)
    • 4.6.1 Controlled Release
    • 4.6.2 Nanotechnology
    • 4.6.3 Bioadhesive Technology
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Active Pharmaceutical Ingredients
    • 4.7.2 Excipients
    • 4.7.3 Preservatives
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Pain Relief
    • 4.8.2 Anti-bacterial
    • 4.8.3 Anti-inflammatory
    • 4.8.4 Tissue Regeneration
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Topical Application
    • 4.9.2 Oral Rinse
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 End User
      • 5.2.1.5 Form
      • 5.2.1.6 Technology
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 End User
      • 5.2.2.5 Form
      • 5.2.2.6 Technology
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 End User
      • 5.2.3.5 Form
      • 5.2.3.6 Technology
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 End User
      • 5.3.1.5 Form
      • 5.3.1.6 Technology
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 End User
      • 5.3.2.5 Form
      • 5.3.2.6 Technology
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 End User
      • 5.3.3.5 Form
      • 5.3.3.6 Technology
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 End User
      • 5.4.1.5 Form
      • 5.4.1.6 Technology
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 End User
      • 5.4.2.5 Form
      • 5.4.2.6 Technology
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 End User
      • 5.4.3.5 Form
      • 5.4.3.6 Technology
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 End User
      • 5.4.4.5 Form
      • 5.4.4.6 Technology
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 End User
      • 5.4.5.5 Form
      • 5.4.5.6 Technology
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 End User
      • 5.4.6.5 Form
      • 5.4.6.6 Technology
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 End User
      • 5.4.7.5 Form
      • 5.4.7.6 Technology
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 End User
      • 5.5.1.5 Form
      • 5.5.1.6 Technology
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 End User
      • 5.5.2.5 Form
      • 5.5.2.6 Technology
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 End User
      • 5.5.3.5 Form
      • 5.5.3.6 Technology
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 End User
      • 5.5.4.5 Form
      • 5.5.4.6 Technology
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 End User
      • 5.5.5.5 Form
      • 5.5.5.6 Technology
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 End User
      • 5.5.6.5 Form
      • 5.5.6.6 Technology
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 End User
      • 5.6.1.5 Form
      • 5.6.1.6 Technology
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 End User
      • 5.6.2.5 Form
      • 5.6.2.6 Technology
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 End User
      • 5.6.3.5 Form
      • 5.6.3.6 Technology
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 End User
      • 5.6.4.5 Form
      • 5.6.4.6 Technology
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 End User
      • 5.6.5.5 Form
      • 5.6.5.6 Technology
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 GlaxoSmithKline
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Colgate-Palmolive
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Procter & Gamble
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Johnson & Johnson
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Sunstar Group
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 3M
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Dentsply Sirona
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Unilever
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Henkel
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Church & Dwight
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Lion Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 GC Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Ivoclar Vivadent
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Straumann Group
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Bausch Health
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Septodont
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Kao Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Mundipharma
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Pierre Fabre
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Haleon
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us